Evidence map›Paper›PMID 42845623›Full record

ArticleResearch square2026

Digital quantification of vascular β-amyloid and perivascular plaques in cerebral amyloid angiopathy.

Paniz Mojdeganlou, Jennifer Poirier, Lisa L Barnes, David A Bennett, Sue E Leurgans, Julie A Schneider, Alifiya Kapasi

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paniz MojdeganlouRush University Medical Center.
Jennifer PoirierRush University Medical Center.
Lisa L BarnesRush University Medical Center.
David A BennettRush University Medical Center.
Sue E LeurgansRush University Medical Center.
Julie A SchneiderRush University Medical Center.
Alifiya KapasiRush University Medical Center.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Small vessel disease contributions to neurodegeneration in Alzheimer's diseaseK01AG075177 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Alifiya Kapasi · 2022 to 2026
$553k
NIA NIH HHS K01 AG075177NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018
6 · The paper itself

Abstract

Introduction: This study aimed to 1) develop a quantitative approach to automate detection of cortical CAA-positive vessels separate from β-amyloid plaques, 2) validate digital pathology classifier for CAA against manual scoring, and 3) characterize the spatial distribution of perivascular β-amyloid plaques in relation to CAA-positive vessels. Methods: Digital pathology classifiers were trained on the HALO AI platform to distinguish cortical CAA-positive vessels from β-amyloid plaques in the calcarine cortex. Classifiers were applied to digitized histopathologic slides (n = 100), previously rated by expert neuropathologists. Slide level digital quantitative measures for CAA (CAA classified area and vascular β-amyloid percent positivity) and for β-amyloid plaques (β-amyloid plaque classified area) were compared with manual CAA scores and Alzheimer's disease neuropathologic change (ADNC). Perivascular plaques, defined as β-amyloid plaques within a 0- to 150-micron concentric distance from the center of CAA-positive vessels, were identified. Results: Participants had a mean age of 91.1 (SD = 5.6) years at death, with 76% being women. Digital pathology quantification for CAA classified area and vascular β-amyloid percent positivity showed strong correlations with semi-quantitative manual CAA scores (r Conclusion: Digital pathology classifiers reliably distinguish cortical CAA vessels from β-amyloid plaques and can be utilized to study plaque proximity to CAA-positive vessels severity, supporting the use of digital pathology to advance understanding of CAA pathogenesis.

Identifiers

PMID42845623
PMCPMC13640908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.